E-LIB Suche - Ergebnisse für: Lo, Ching-Chu

1

THU-365 Real-world effectiveness and safety of 8-week gleca..:

Huang, Chung-Feng ; Chang, Te-Sheng ; Kuo, Hsing-Tao...
Journal of Hepatology. 80 (2024) - p. S832-S833 , 2024

2

A therapeutic dose and its pharmacokinetics of ropeginterfe..:

Lo, Ching-Chu ; Chuang, Wan-Long ; Kuo, Hsing-Tao...
Journal of the Formosan Medical Association. 123 (2024) 1 - p. 55-61 , 2024

Link: https://doi.org/10.1016/..

3

An algorithm for simplified hepatitis C virus treatment wit..:

Yu, Ming-Lung ; Tai, Chi‐Ming ; Mo, Lein-Ray...
Hepatology International. 18 (2024) 2 - p. 461-475 , 2024

Link: https://doi.org/10.1007/..

4

Metformin and statins reduce hepatocellular carcinoma risk ..:

Tsai, Pei-Chien ; Huang, Chung-Feng ; Yeh, Ming-Lun...
Clinical and Molecular Hepatology. , 2024

Link: https://doi.org/10.3350/..

5

Real-World Efficacy and Safety of Universal 8-Week Glecapre..:

Yang, Chun-Chi ; Huang, Chung-Feng ; Chang, Te-Sheng...
Infectious Diseases and Therapy. 13 (2024) 6 - p. 1199-1213 , 2024

Link: https://doi.org/10.1007/..

6

Metformin reduces hepatocellular carcinoma incidence after ..:

Tsai, Pei-Chien ; Kuo, Hsing-Tao ; Hung, Chao-Hung...
Journal of Hepatology. 78 (2023) 2 - p. 281-292 , 2023

Link: https://doi.org/10.1016/..

7

Effectiveness and safety of 8-week glecaprevir/pibrentasvir..:

Chang, Te-Sheng ; Huang, Chung-Feng ; Kuo, Hsing-Tao...
Hepatology International. 17 (2023) 3 - p. 550-561 , 2023

Link: https://doi.org/10.1007/..

8

Artificial intelligence predicts direct-acting antivirals f..:

Lu, Ming-Ying ; Huang, Chung-Feng ; Hung, Chao-Hung...
Clinical and Molecular Hepatology. 30 (2023) 1 - p. 64-79 , 2023

Link: https://doi.org/10.3350/..

9

Micro-elimination of hepatitis C virus infection in the rur..:

Lo, Ching-Chu ; Lei, Wei-Yi ; Huang, Ying-Che...
Journal of Microbiology, Immunology and Infection. 56 (2023) 4 - p. 680-687 , 2023

Link: https://doi.org/10.1016/..

10

The impact of HCV cure on glycemic indices in patients usin..:

Huang, Chung-Feng ; Kuo, Hsing-Tao ; Chang, Te-Sheng...
Journal of Hepatology. 78 (2023) - p. S1180-S1182 , 2023

Link: https://doi.org/10.1016/..

11

Sofosbuvir/velpatasvir/voxilaprevir for patients with chron..:

Liu, Chen-Hua ; Peng, Cheng-Yuan ; Liu, Chun-Jen...
Hepatology International. 17 (2023) 2 - p. 291-302 , 2023

Link: https://doi.org/10.1007/..

12

Micro-elimination of Hepatitis C virus infection in mountai..:

Lo, Ching-Chu ; Lei, Wei-Yi ; Huang, Ying-Che...
Journal of Hepatology. 78 (2023) - p. S895-S896 , 2023

Link: https://doi.org/10.1016/..

13

Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection:..:

Lo, Ching-Chu ; Huang, Chung-Feng ; Cheng, Pin-Nan...
Journal of the Formosan Medical Association. 121 (2022) 8 - p. 1567-1578 , 2022

Link: https://doi.org/10.1016/..

14

Factors Associated with Significant Platelet Count Improvem..:

Chen, Yen-Chun ; Chang, Te-Sheng ; Chen, Chien-Hung...
Viruses. 14 (2022) 2 - p. 333 , 2022

Link: https://doi.org/10.3390/..

15

Effectiveness and safety of 8-week glecaprevir/pibrentasvir..:

Hung, Chao-Hung ; Chang, Te-Sheng ; Huang, Chung-Feng...
Journal of Hepatology. 77 (2022) - p. S595-S596 , 2022

Link: https://doi.org/10.1016/..